Specialty code 1835P0018X · Wilmington, NC
NPI
1558712729
Since 2016
Specialty
Specialty code 1835P0018X
Code 1835P0018X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1605 Doctors Cir
Wilmington, NC, 28401
Phone (910) 353-8736
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$9.0M
6,192 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Glenn H Herrington prescribed most often to Medicare patients was Eliquis (Apixaban), with 1,900 prescriptions and refills. In total Glenn H Herrington wrote 6,192 Medicare prescriptions that cost $9.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Eliquis Apixaban | 1,900 | 5,586 | 914 | $3.1M |
| Entresto Sacubitril/Valsartan | 836 | 2,408 | 277 | $1.4M |
| Farxiga Dapagliflozin Propanediol | 645 | 1,855 | 216 | $985K |
| Jardiance Empagliflozin | 605 | 1,747 | 218 | $972K |
| Xarelto Rivaroxaban | 490 | 1,429 | 214 | $755K |
| Ozempic Semaglutide | 342 | 683 | 101 | $622K |
| Dofetilide Generic | 138 | 384 | 73 | $40K |
| Trulicity Dulaglutide | 112 | 193 | 25 | $183K |
| Metoprolol Succinate Generic | 83 | 203 | 32 | $1,463 |
| Multaq Dronedarone Hcl | 66 | 185 | 43 | $135K |
| Mounjaro Tirzepatide | 63 | 95 | 17 | $100K |
| Repatha Sureclick Evolocumab | 58 | 156 | 23 | $88K |
| Spironolactone Generic | 51 | 110 | 15 | $222 |
| Rosuvastatin Calcium Generic | 41 | 121 | 18 | $758 |
| Livalo Pitavastatin Calcium | 40 | 110 | 14 | $22K |
Brand drugs: 5,423 claims; generic drugs: 769 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Glenn H Herrington were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.